IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

INTRODUCTION: Patients with atrial fibrillation frequently suffer from heart failure with preserved ejection fraction. At present there is no proven therapy to improve physical capacity and quality of life in participants with permanent atrial fibrillation with preserved left ventricular contractili...

Descripción completa

Detalles Bibliográficos
Autores principales: Shantsila, Eduard, Haynes, Ronnie, Calvert, Melanie, Fisher, James, Kirchhof, Paulus, Gill, Paramjit S, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073497/
https://www.ncbi.nlm.nih.gov/pubmed/27707827
http://dx.doi.org/10.1136/bmjopen-2016-012241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073497/
https://www.ncbi.nlm.nih.gov/pubmed/27707827
http://dx.doi.org/10.1136/bmjopen-2016-012241

Ejemplares similares